LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
Study Information
Alliance Study ID: NCCTG-983253
NCT Study ID (ClinicalTrials.gov): NCT00006007
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Alex A. Adjei, MD, PhD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining LY231514 plus gemcitabine in treating women who have metastatic breast cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information